This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Peptides targeting EGFR enhance diagnostic sensitivity for various cancers.
Why it matters
Improving cancer diagnosis can lead to earlier detection and better treatment outcomes. Targeting EGFR with peptides may provide a more effective approach than traditional methods.
How the study worked
The study is a review summarizing various peptide-based diagnostic technologies and their applications.
What this study cannot tell us
As a review, it does not present new experimental data but summarizes existing studies, which may vary in quality.
Read the original research
Innovative Diagnostic Peptide-Based Technologies for Cancer Diagnosis: Focus on EGFR-Targeting Peptides.
ChemMedChem, 18(3), e202200506
Citation
Ahmadi, Mohammad; Ahmadyousefi, Yaghoub; Salimi, Zahra; Mirzaei, Rasoul; Najafi, Rezvan; Amirheidari, Bagher; Rahbarizadeh, Fatemeh; Kheshti, Javad; Safari, Armin; Soleimani, Meysam. (2023). Innovative Diagnostic Peptide-Based Technologies for Cancer Diagnosis: Focus on EGFR-Targeting Peptides.. ChemMedChem, 18(3), e202200506. https://doi.org/10.1002/cmdc.202200506